Summary
Thirty-eight patients with virologically proven dendritic keratitis were treated using either debridement plus human leukocyte interferon (HLI) or debridement plus human fibroblast interferon (HFI) in a randomized, doubleblind study. We administered one drop of HLI or HFI (1×106 reference units/ml) daily and found no significant difference in the action of either type of interferon.
Zusammenfassung
38 Patienten mit virologisch verifizierter Keratitis dendritica wurden in einer randomisierten Doppelblindstudie entweder mit Abrasio plus Humanleukozyteninterferon (HLI) oder Abrasio plus Humanfibroblasteninterferon (HFI) behandelt. Nur ein Tropfen Interferon (1×106 Einheiten/ml) wurde täglich gegeben. Es fand sich kein signifikanter Unterschied zwischen der Wirkung beider Interferone.
Similar content being viewed by others
References
Cantell, K.: Prospects for clinical use of exogenous interferon. Med. Biol. 55, 69–73 (1977)
Cantell, K., Hirvonen, S., Morgensen, K.E., Pyhälä, L.: Human leukocyte interferon production, purification, stability and animal experiments. In: Waymouth C. (ed.), Proceedings of a Tissue Culture Association Workshop, In Vitro, pp. 35–38, Monograph No 3, Rockville, Maryland (1974)
Dahl, M., Degré, M.: A microassay for mouse and human interferon. Acta Pathol. Microbiol. Scand.; Section B. 80, 863–870 (1972)
Einhorn, S., Strander, H.: Is interferon tissue specific? — Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines. J. Gen. Virol. 35, 573–577 (1977)
Havell, E.A., Vilcek, J.: Production of high-titered interferon in cultures of human diploid cells. Antimicrob. Agents Chemother. 2, 476–484 (1972)
Jones, B.R., Coster, D.J., Falcon, M.G., Cantell, K.: Topical therapy of ulcerative herpetic keratitis with human interferon. Lancet, 1976II, 128
Neumann-Haefelin, D., Sundmacher, R., Skoda, R., Cantell, K.: Comparative evaluation of human leukocyte and fibroblast interferon in the prevention of herpes simplex virus keratitis in a monkey model. Infect. Immun. 17, 468–470 (1977)
Sundmacher, R., Cantell, K., Haug, P., Neumann-Haefelin, D.: Role of debridement and interferon in the treatment of dendritic keratitis. Albrecht v. Graefes Arch. klin. Ophthal. 207, 77–82 (1978)
Sundmacher, R., Neumann-Haefelin, D., Cantell, K.: Successful treatment of dendritic keratitis with human leukocyte interferon. A controlled clinical study. Albrecht v. Graefes Arch. klin. exp. Ophthal. 201, 39–45 (1976)
Author information
Authors and Affiliations
Additional information
With support from the Deutsche Forschungsgemeinschaft
Rights and permissions
About this article
Cite this article
Sundmacher, R., Cantell, K., Skoda, R. et al. Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis. Albrecht von Graefes Arch. Klin. Ophthalmol. 208, 229–233 (1978). https://doi.org/10.1007/BF00419377
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00419377